Invest in Quorum X Diagnostics

The first 4-minute at-home Antigen test for COVID

EARLY BIRD TERMS: $33,650 LEFT

$16,350

of a $1,970,000 goal

INVEST

min $100

INVESTMENT TERMS

$25M$20Mvaluation cap Future Equity

$250, $500, $1K, $10K

LEAD INVESTOR

Covid19 has changed all of our lives. Even as vaccines are widely available, there is still a significant need for rapid testing at long term care facilities, sporting events, cruise ships, internationally, and a multitude of other applications. COVIDNOW can meet this need. In addition to Covid19, the technology that Maria and her team have developed could potentially be applied to other conditions, such as the test for Pseudomonal Pneumonia. Can you envision a future where people can quickly and cheaply test for various ailments as opposed to lengthy, tedious, expensive doctor's visits or blood work? I can; Quorum X Diagnostics has that potential. Further, having talked with Maria on multiple occasions, it is clear she is deeply passionate about Quorum X Diagnostics and their mission. This is in addition to her being a brilliant scientist, sophisticated businesswoman, and great leader. She and her team have proven their ability to execute over the past year, and I am confident that she will continue to do so. Together, we can enhance the world (and potentially earn a sizeable return, evidenced by Quorum X Diagnostic's significant increase in valuation since the last round). Will you join us?

Pitch Video

Investor Panel

quorumxdiagnostics.com

Atlanta GA

Technology Bio Tech Hard Tech Medical Device Life Science

Highlights

The first 4-minute, fully at-home COVID Antigen test.

No prescription needed; an OTC test kit identifying an active COVID infection in less than 4 mins.

We have a working prototype, official clinical data, and a EUA submission.

Our Team! Our team consists of 2 Ph.D. scientist founders and 5 Active Advisers (all M.D., Ph.D.'s, or MBA).

Incubators- YCombinator Online StartUp School Su18, Su19, and Su20 and John Hopkins Su18.

Our Team

Global need. We realized we could use the same unique technology (that was used to build our QXD-1 Fast test for Pseudomonal Pneumonia) and use it to build a test for COVID.

The first 4-minute at-home Antigen test for COVID

Quorum X Diagnostics (QXD), is a medical diagnostics startup that was founded in 2017 to produce an effective yet simple and fast diagnostic test for Pseudomonas pneumonia to be used in physicians’ offices and/or clinics. The idea is that the test would provide real-time results without having to send samples off to a lab.

In the Spring of 2020, in the wake of the COVID-19 pandemic, the scientific team quickly realized that the same unique proprietary technology could be used to develop an at-home diagnostic test for SARS-CoV-2 (COVID-19) that would provide real-time results in 4 minutes and detect an active COVID-19 infection (even if an individual is asymptomatic).

An Emergency Use Authorization (EUA) has been submitted to the U. S. FDA. EUA approval is pending. (Please note: the image above is a design prototype)

During this transition period from quarantine and isolation to regaining life as it was before the pandemic, the need for rapid testing for Covid continues.

HIGHLIGHTS:

The 4-minute COVIDNOW® antigen test currently has the fastest development time compared to competitive products that currently have EUA approval.
COVIDNOW® is SIMPLE. It was designed to be easy to make self-testing at-home a viable option for everyone!
QXD’s COVIDNOW® test is an antigen test vs. an antibody test meaning it can detect active infection.
The sensitivity of the COVIDNOW® test is able to detect an active infection in asymptomatic individuals.
COVIDNOW® does not require a prescription.
The COVIDNOW® APP uses the latest in A.I. technology making it possible to analyze the test cassette result much sharper than that of the naked eye.
The sample from the COVIDNOW® test does not have to be sent off to a lab; it is not a collection kit.
Everything needed to complete the test is included in the COVIDNOW® test kit package.
QXD has partnered with Physician 360, a telemedicine service, to provide immediate connectivity to a board-certified physician for a consultation.
The QXD COVIDNOW® at-home test kit has a mobile phone APP that using AI technology and works in conjunction with the telemedicine service.
QXD's partnership with Physician 360, the telemedicine service, provides an additional distribution channel through P360 kiosks located in 1,000+ stores across all 50 states.
All patent applications required for the proprietary technology used to produce QXD’s rapid diagnostic tests have been submitted and are currently pending.
Clinical trials have been finalized and the application for an Emergency Use Authorization (EUA) has been submitted to the FDA.
Should Quorum X Diagnostics not receive the EUA from the FDA, it still has the QXD-1 Fast Test for Pseudomonal pneumonia as well as other similar rapid diagnostics tests in the pipeline.
QXD has a clear exit strategy. Within five years continue the development of the proprietary technology and build out the scientific and organizational infrastructure of the business model at which point it would be optimal for a larger corporation to take the vision to the next level.
COVIDNOW® is pending EUA approval

Making an investment is a huge decision and one that we don’t take lightly. Rest assured, we are dedicated, determined, and passionate about what we are doing.

QXD has an amazing team and we're the team to get it DONE!

Downloads

GOA2-COVID NOW-Final pitch QXD Powerpoint 1 .pdf